Compare MTW & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTW | BBNX |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | 4700 | 423 |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.1M | 493.1M |
| IPO Year | 1994 | N/A |
| Metric | MTW | BBNX |
|---|---|---|
| Price | $13.59 | $10.35 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $10.50 | ★ $23.80 |
| AVG Volume (30 Days) | 142.4K | ★ 1.1M |
| Earning Date | 05-05-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $2,240,900,000.00 | N/A |
| Revenue This Year | $4.73 | $34.90 |
| Revenue Next Year | $2.98 | $34.63 |
| P/E Ratio | $67.90 | ★ N/A |
| Revenue Growth | ★ 2.89 | N/A |
| 52 Week Low | $7.58 | $8.80 |
| 52 Week High | $15.56 | $32.71 |
| Indicator | MTW | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 42.90 |
| Support Level | $12.34 | $9.36 |
| Resistance Level | $14.33 | $11.92 |
| Average True Range (ATR) | 0.47 | 1.00 |
| MACD | 0.08 | -0.14 |
| Stochastic Oscillator | 81.60 | 18.35 |
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.